ArticleNeuro-oncology advances

Combined inhibition of lysine-specific demethylase 1 and kinase signaling as a preclinical treatment strategy in glioblastoma.

Lea M Stitzlein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.